Zobrazeno 1 - 10
of 206
pro vyhledávání: '"A, Hastillo"'
Autor:
Abbate, Antonio, Kontos, Michael C., Grizzard, John D., Biondi-Zoccai, Giuseppe G.L., Van Tassell, Benjamin W., Robati, Roshanak, Roach, Lenore M., Arena, Ross A., Roberts, Charlotte S., Varma, Amit, Gelwix, Christopher C., Salloum, Fadi N., Hastillo, Andrea, Dinarello, Charles A., Vetrovec, George W.
Publikováno v:
In The American Journal of Cardiology 2010 105(10):1371-1377
Autor:
Charlotte Roberts, George W. Vetrovec, Vigheshwar Kasirajan, Gaetano Antonio Lanza, Keyur B. Shah, Anthony D. Cassano, Antonio Abbate, Filippo Crea, Ryan Melchior, Hastillo A, Maged Hamza, John D. Grizzard
Publikováno v:
International Journal of Cardiology. 161:e7-e9
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::04a9096c7e818834a6bbc76090b891bd
https://doi.org/10.1016/j.ijcard.2012.03.006
https://doi.org/10.1016/j.ijcard.2012.03.006
Autor:
Mohammed A. Nayeem, Gary T. Elliott, Rakesh C. Kukreja, Maulik Shah, Samantha L Hastillo-Hess
Publikováno v:
Journal of Molecular and Cellular Cardiology. 29:2305-2310
We examined the in vitro preconditioning effect of non-toxic derivative of endotoxin, monophosphoryl lipid A (MLA) in adult rat cardiac myocytes. Cultured 5-7-day-old myocytes were preconditioned for 4 h by treatment with 200 ng/ml MLA. Twenty h late
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80fbace30ffe9f40fd0bea292a97c48e
https://doi.org/10.1006/jmcc.1997.0452
https://doi.org/10.1006/jmcc.1997.0452
Publikováno v:
The American Journal of the Medical Sciences. 311:286-291
Milrinone (Inocor-Sanofi-Winthrop) represents a second generation phosphodiesterase inhibitor currently approved for intravenous administration in the treatment of decompensated congestive heart failure. By inhibiting Type III phosphodiesterase, milr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::739b720c3b224352689e3837d3f08b39
https://doi.org/10.1016/s0002-9629(15)41723-9
https://doi.org/10.1016/s0002-9629(15)41723-9
Autor:
Andrea K. Hastillo, Andrew S. Wechsler, Albert Guerraty, K. Francis Lee, Janet D. Pierce, Michael L. Hess
Publikováno v:
The Annals of Thoracic Surgery. 52:211-218
To assess the long-term safety of an immunosuppressive regimen without corticosteroids, we retrospectively evaluated 42 long-term (greater than 1 year) survivors of orthotopic cardiac transplantation. We determined the incidence of (1) conversion of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::171c5d0ce87602f5b1d098285c1732b4
https://doi.org/10.1016/0003-4975(91)91338-v
https://doi.org/10.1016/0003-4975(91)91338-v
Autor:
James A. Thompson, Jhulan Mukharji, Roger B. Rehr, George W. Vetrovec, Michael L. Hess, Walter H. J. Paulsen, Hastillo A
Publikováno v:
Clinical Cardiology. 13:639-643
The importance of atrial contribution to cardiac function in patients with congestive heart failure is controversial. Ten patients with severe congestive failure (Group A) and 10 patients with normal ventricular function (Group B) were studied during
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09265da4385cf9b71cd8ec448561da09
https://doi.org/10.1002/clc.4960130910
https://doi.org/10.1002/clc.4960130910
Autor:
Hastillo A, Ayres Sm
Publikováno v:
Critical Care Medicine. 20:566-568
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::373d7872f75f262ce475ad9e7c7ce903
https://doi.org/10.1097/00003246-199205000-00003
https://doi.org/10.1097/00003246-199205000-00003
Publikováno v:
The American journal of the medical sciences. 311(6)
Milrinone (Inocor-Sanofi-Winthrop) represents a second generation phosphodiesterase inhibitor currently approved for intravenous administration in the treatment of decompensated congestive heart failure. By inhibiting Type III phosphodiesterase, milr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::263dc3269a61dceba02f23ba6b8cba2d
https://pubmed.ncbi.nlm.nih.gov/8659556
https://pubmed.ncbi.nlm.nih.gov/8659556
Autor:
A, Hastillo, M L, Hess
Publikováno v:
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 12(1 Pt 1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7db52bf03715137ad695a0fb86264543
https://pubmed.ncbi.nlm.nih.gov/8241231
https://pubmed.ncbi.nlm.nih.gov/8241231
Publikováno v:
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 10(1 Pt 1)
Coronary artery disease remains a significant long-term problem for survival after heart transplantation. Hyperlipidemia is a known risk factor for coronary artery disease in the general population, but the role of hyperlipidemia in cardiac allograft
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::64598fb4a6a6c83b5ece85b5bee76e81
https://pubmed.ncbi.nlm.nih.gov/2007170
https://pubmed.ncbi.nlm.nih.gov/2007170